Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit https://cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Log in

Singal, Amit

Open Protocols

Protocol Name	Investigatory Role	Biomarkers	Data Collections
Clinical Validation Center for Hepatocellular Carcinoma	Coordinating	0	0
HEDS Ref Set App: Hoshida (2024) Validation of etiology-specific "plug-in" PLSec assays	Involved	0	0
HEDS Ref Set App: Singal (2024) Longitudinal changes in PLSec biomarker and HCC risk in the HEDS cohort	Involved	0	0
Hepatocellular carcinoma Early Detection Strategy study	Involved	1	0
National Liver Cancer Screening Trial (TRACER)	Leading	0	0

Closed Protocols

Protocol Name	Investigatory Role	Biomarkers	Data Collections
HEDS Reference Set Application: Amit Singal, UTSW (2021) Prognostic Liver Secretome signature Validation	Leading	0	0
Liver Rapid Reference Set Mehta-Singal (2022)	Involved	0	0

Publications

Publication Name	PubMed ID	Journal
A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation.	36497452	Cancers (Basel)
Blood-Based Biomarkers for HCC Surveillance: Ready for the Center Stage?	37795908	Am J Gastroenterol
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.	16137783	J Hepatol
Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis.	18045939	J Virol
Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease.	36402450	J Hepatol
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.	15726646	Hepatology
Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy.	37129867	Liver Transpl

Interests

Hepatocellular carcinoma: My research focuses on risk stratification and early detection of liver cancer in patients with cirrhosis, including evaluation of emerging blood- and imaging-based screening strategies.

To update protocols, publications, biomarkers, or science data, please contact the Data Management and Coordinating Center.

Site: UT Southwestern Medical Center
Degree(s): M.D.
Email: amit.singal@utsouthwestern.edu
Person ID: 4686
EDRN Title: EDRN Principal Investigator
Note: To update contact information, please visit the Data Management and Coordinating Center .